RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia by Holly Edwards, Chengzhi Xie,

Slides:



Advertisements
Similar presentations
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Advertisements

Up-Regulation of Activating Transcription Factor-5 Suppresses SAP Expression to Activate T Cells in Hemophagocytic Syndrome Associated with Epstein-Barr.
by Elena A. Federzoni, Peter J. M. Valk, Bruce E
MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome by Lital Shaham, Elena Vendramini, Yubin Ge, Yaron Goren, Yehudit Birger,
MicroRNA-21 Expression in CD4+ T Cells Is Regulated by STAT3 and Is Pathologically Involved in Sézary Syndrome  Leslie van der Fits, Marloes S. van Kester,
The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells by Rossana Trotta, David Ciarlariello, Jessica Dal Col, Hsiaoyin Mao,
Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells by Weiqing.
Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells by Takayuki Ikezoe, Sakae Tanosaki, Utz Krug,
4EBP1/c-MYC/PUMA and NF-κB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells by Seongseok Yun, Nicole D. Vincelette,
by Ji-Long Chen, Andre Limnander, and Paul B. Rothman
The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia by Shuchi Agrawal, Wolf-Karsten Hofmann, Nicola Tidow, Mathias Ehrich,
The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCθ and ERK pathways by Gilles Despouy, Marjorie Joiner, Emilie Le Toriellec,
by Paritosh Ghosh, Meredith A
A novel TNFR1-triggered apoptosis pathway mediated by class IA PI3Ks in neutrophils by Barbara Geering, Ursina Gurzeler, Elena Federzoni, Thomas Kaufmann,
Yongping Shao, Kaitlyn Le, Hanyin Cheng, Andrew E. Aplin 
EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression
FOG-1 represses GATA-1-dependent FcϵRI β-chain transcription: transcriptional mechanism of mast-cell-specific gene expression in mice by Keiko Maeda, Chiharu.
CD74 induces TAp63 expression leading to B-cell survival
Overexpression of survivin in primary ATL cells and sodium arsenite induces apoptosis by down-regulating survivin expression in ATL cell lines by Xiao-Fang.
Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells by Duohui Jing, Vivek A.
Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia by Xue-Fei Huang, Shao-Kai Luo,
by Daniel Sasca, Patricia S
MafB negatively regulates RANKL-mediated osteoclast differentiation
by Daniela Buglio, Noor M
Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition by Jinsong Hu, Nana Dang, Eline Menu, Elke De Bryune, Dehui Xu, Ben Van.
Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells by Aleksandar Petlickovski,
PTF1α/p48 and cell proliferation
Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation by Shiguo Zhu, Prasad V. Phatarpekar,
by Susana Constantino Rosa Santos, and Sérgio Dias
Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor κB target genes and induction of apoptosis in chronic.
by Beatriz Bellosillo, Mireia Dalmau, Dolors Colomer, and Joan Gil
Vascular endothelial growth factor stimulates protein kinase CβII expression in chronic lymphocytic leukemia cells by Simon T. Abrams, Benjamin R. B. Brown,
Volume 16, Issue 9, Pages (August 2016)
An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti–IL-6 antibody-induced.
Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone.
The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia by Christine Le Roy, Pierre-Antoine Deglesne, Nathalie.
by Gregory H. Underhill, David George, Eric G. Bremer, and Geoffrey S
Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells by Bing Z. Carter, Marcela Gronda,
by Sansana Sawasdikosol, Kristin M. Russo, and Steven J. Burakoff
CD7-restricted activation of Fas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukemia by Edwin Bremer, Bram ten Cate, Douwe F. Samplonius,
Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival by Kyu-Tae Kim, Kristin Baird, Joon-Young Ahn, Paul.
by Kentson Lam, Alexander Muselman, Randal Du, Yuka Harada, Amanda G
Volume 17, Issue 3, Pages (February 2005)
Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML)‏ by Michaela Scherr, Anuhar Chaturvedi, Karin.
by Reuben Kapur, Ryan Cooper, Lei Zhang, and David A. Williams
MiR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53 by Francisco Navarro, David Gutman, Eti Meire, Mario Cáceres,
Enxuan Jing, Stephane Gesta, C. Ronald Kahn  Cell Metabolism 
Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma by Hanna Karvonen, David Chiron, Wilhelmiina Niininen,
The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy by Suhu Liu, Anna E. Marneth, Gabriela.
Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia by Jianting Long, Brian.
Promotion Effects of miR-375 on the Osteogenic Differentiation of Human Adipose- Derived Mesenchymal Stem Cells  Si Chen, Yunfei Zheng, Shan Zhang, Lingfei.
Myeloma cell–derived Runx2 promotes myeloma progression in bone
ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression
Volume 128, Issue 7, Pages (June 2005)
PPARδ Is a Type 1 IFN Target Gene and Inhibits Apoptosis in T Cells
Green Tea Polyphenol Epigallocatechin-3-Gallate Suppresses Collagen Production and Proliferation in Keloid Fibroblasts via Inhibition of the STAT3-Signaling.
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Volume 26, Issue 3, Pages (May 2007)
Volume 67, Issue 6, Pages (June 2005)
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Volume 18, Issue 3, Pages (March 2010)
Volume 70, Issue 5, Pages (September 2006)
AML cells display differential sensitivity to inhibition of IKBKE and TBK1. AML cells display differential sensitivity to inhibition of IKBKE and TBK1.
Shipra Das, Olga Anczuków, Martin Akerman, Adrian R. Krainer 
Correlation of MAGE-A1 expression with PFS in patients treated with FRD and knockdown of MAGE-A in HMCLs. MAGE-A1 expression is correlated with resistance.
Volume 16, Issue 5, Pages (May 2009)
The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.
Changes in signal transduction pathway induced by gefitinib.
Effect of SFN on the total activity and protein expression of HDACs in JB6 P+ cells. Effect of SFN on the total activity and protein expression of HDACs.
Presentation transcript:

RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia by Holly Edwards, Chengzhi Xie, Katherine M. LaFiura, Alan A. Dombkowski, Steven A. Buck, Julie L. Boerner, Jeffrey W. Taub, Larry H. Matherly, and Yubin Ge Blood Volume 114(13):2744-2752 September 24, 2009 ©2009 by American Society of Hematology

Real-time RT-PCR quantification of RUNX1 transcripts in megakaryoblasts from children with and children without DS newly diagnosed with AMkL. Real-time RT-PCR quantification of RUNX1 transcripts in megakaryoblasts from children with and children without DS newly diagnosed with AMkL. Transcript levels for RUNX1a, RUNX1b/1c, and RUNX1c were measured by real-time RT-PCR and normalized to 18S rRNA levels. RUNX1b transcript levels were calculated by subtracting RUNX1c transcript levels from the total transcript levels for RUNX1b/1c. The horizontal lines indicate median RUNX1 transcript levels in each group of patient samples. The P value was determined by the nonparametric Mann-Whitney U test. Holly Edwards et al. Blood 2009;114:2744-2752 ©2009 by American Society of Hematology

shRNA knockdown of RUNX1 in Meg-01 cells resulted in increased sensitivity to ara-C. shRNA knockdown of RUNX1 in Meg-01 cells resulted in increased sensitivity to ara-C. (A-B) Meg-01 cells were infected by RUNX1 shRNA lentivirus clones. After selection with puromycin, infected Meg-01 cells were plated in soft agar. Colonies were isolated, expanded, and tested for RUNX1 expression by real-time RT-PCR (A) and Western blotting (B). Two colonies (designated RUNX1 1-1 and RUNX1 1-2) with decreased RUNX1 gene expression were selected as candidates for further study. A pool of cells from the negative control transduction was used as the control (designated negative). (C) The RUNX1 1-1, RUNX1 1-2, and negative cells were cultured in complete medium with dialyzed FBS in 96-well plates at a density of 4 × 104 cells/mL. Cells were cultured continuously with a range of concentrations of ara-C at 37°C, and cell numbers were determined with the Cell Titer–blue reagent and a fluorescence microplate reader. The data represent mean values ± SEs from at least 3 independent experiments. Holly Edwards et al. Blood 2009;114:2744-2752 ©2009 by American Society of Hematology

Overlapping genes between the oligonucleotide microarray dataset derived from Meg-01 shRNA stable clones and the Affymetrix microarray dataset derived from primary DS and non-DS AMkL patient blasts. Overlapping genes between the oligonucleotide microarray dataset derived from Meg-01 shRNA stable clones and the Affymetrix microarray dataset derived from primary DS and non-DS AMkL patient blasts. (A) Differentially expressed genes identified by oligonucleotide microarray from Meg-01–negative and RUNX1 1-1 cells (left circle) were cross referenced, by comparing GenBank accession numbers, with genes differentially expressed between primary DS and non-DS AMkL patient specimens identified by Affymetrix microarray (right circle) in our previous study.27 A total of 351 probes (supplemental Table 7) were identified in both microarray datasets (overlapping area), including PIK3CD. (B) Transcript levels for PIK3CD were quantitated by real-time RT-PCR in the Meg-01 shRNA stable clones to validate the oligonucleotide microarray data. Real-time PCR results were expressed as mean values from 3 independent experiments with the same cDNA preparation and normalized to 18S rRNA. **Statistically significant differences (P < .005). Error bars indicate SEs. (C-D) PIK3CD transcript levels in primary DS and non-DS AMkL blasts were quantitated by real-time RT-PCR. Median PIK3CD transcript levels were compared between the 2 patient groups with the use of the nonparametric Mann-Whitney U test (C), and their relation to RUNX1b transcript levels was determined by the nonparametric Spearman rank correlation coefficient (D). Holly Edwards et al. Blood 2009;114:2744-2752 ©2009 by American Society of Hematology

PIK3CD is a bona fide RUNX1 target gene in AMkL. PIK3CD is a bona fide RUNX1 target gene in AMkL. (A-C) In vivo binding of RUNX1 to the putative RUNX1 binding sites located in the upstream region of the PIK3CD gene (A) in Meg-01 cells was determined by ChIP assays with the use of regular PCR (B) and real-time PCR (C), as described in “Methods.” (D-E) KA1b cells were transfected with pGL3Basic-PIK3CDpro along with pRLSV40 by electroporation. The transfected cells were split into 2 equal aliquots with 1 induced by 2 μg/mL Dox. Cells were harvested 24 hours after transfection, and induction of RUNX1b was determined by Western blotting (D) and luciferase activities were assayed (E) as described in “Methods.” **Statistically significant differences (P < .005). (C and E) Error bars indicate SEs. Holly Edwards et al. Blood 2009;114:2744-2752 ©2009 by American Society of Hematology

Functional impact of RUNX1 on PI3-kinase/Akt signaling and cell apoptosis in Meg-01 cells. Functional impact of RUNX1 on PI3-kinase/Akt signaling and cell apoptosis in Meg-01 cells. (A) The RUNX1 1-1, RUNX1 1-2, and negative stable clones were lysed in PBS buffer containing both protease and phosphatase inhibitors. Soluble proteins were analyzed by Western blots with anti-p110δ, anti–ph-Akt, and anti-Akt antibodies. Intensity of each band was quantified with the use of the Odyssey software. Protein levels for p110δ and Ph-Akt in RUNX1 1-1 and RUNX1 1-2 cells are presented relative to that in negative cells after normalization to levels of total Akt. (B) Baseline apoptosis in the RUNX1 1-1, RUNX1 1-2, and negative stable clones was determined by flow cytometry with annexin V-fluorescein isothiocyanate/propidium iodide staining. **Statistically significant differences (P < .005). Error bars indicate SEs. Holly Edwards et al. Blood 2009;114:2744-2752 ©2009 by American Society of Hematology

Synergistic antileukemia activity between the PI3-kinase inhibitor, LY294002, and ara-C in Meg-01 cells and primary blasts from children without DS with AMkL. Synergistic antileukemia activity between the PI3-kinase inhibitor, LY294002, and ara-C in Meg-01 cells and primary blasts from children without DS with AMkL. (A) Meg-01 cells were harvested and lysed after incubation with a range of concentrations of the nonselective PI3-kinase inhibitor, LY294002, for 48 hours. Soluble proteins were subjected to Western blots probed with anti-Akt and anti–ph-Akt antibodies. (B) Meg-01 cells were continuously cultured in 96-well plates for 96 hours in dialyzed FBS in the presence of various concentrations of LY294002. Cell numbers were determined by the Cell Titer–blue reagents, as described in “Methods.” (C) Ara-C IC50 values were determined in Meg-01 cells in the presence of different concentrations of LY294002. *Statistically significant differences (P < .05); **statistically significant differences (P < .005). (B-C) Error bars indicate SEs. (D) Standard isobologram analysis of Meg-01 cell growth inhibition by LY294002 and ara-C in combination. The IC50 values of each drug are plotted; the solid line represents the additive effect, whereas the points represent the concentrations of each drug resulting in 50% growth inhibition. (E-F) Ara-C IC50 values were determined in the presence of a range of concentrations of LY294002 in 2 primary AMkL blasts from 2 children newly diagnosed with de novo AMkL by MTT assay as described in “Methods.” Holly Edwards et al. Blood 2009;114:2744-2752 ©2009 by American Society of Hematology